BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34275207)

  • 1. Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study.
    Tittel SR; Laubner K; Schmid SM; Kress S; Merger S; Karges W; Wosch FJ; Altmeier M; Pavel M; Holl RW;
    J Diabetes; 2021 Dec; 13(12):1007-1014. PubMed ID: 34275207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature.
    Lo Preiato V; Salvagni S; Ricci C; Ardizzoni A; Pagotto U; Pelusi C
    Rev Endocr Metab Disord; 2021 Jun; 22(2):337-349. PubMed ID: 33409866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus in Friedreich Ataxia: A case series of 19 patients from the German-Austrian diabetes mellitus registry.
    Pappa A; Häusler MG; Veigel A; Tzamouranis K; Pfeifer MW; Schmidt A; Bökamp M; Haberland H; Wagner S; Brückel J; de Sousa G; Hackl L; Bollow E; Holl RW
    Diabetes Res Clin Pract; 2018 Jul; 141():229-236. PubMed ID: 29763710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year mortality after acute myocardial infarction in patients with different diabetic status.
    Fojt A; Kowalik R; Gierlotka M; Gąsior M; Smeding C; Opolski G
    Pol Arch Intern Med; 2021 Nov; 131(11):. PubMed ID: 34581173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital - A Tertiary Referral Center.
    Preechasuk L; Tantasuwan S; Likitmaskul S; Santiprabhob J; Lertbannaphong O; Plengvidhya N; Tangjittipokin W; Nitiyanant W; Lertwattanarak R
    Diabetes Metab Syndr Obes; 2022; 15():1375-1387. PubMed ID: 35528720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic Criteria.
    Angelousi A; Ziogas DC; Siampanopoulou V; Mytareli C; Anastasopoulou A; Lyrarakis G; Gogas H
    Diseases; 2024 Feb; 12(2):. PubMed ID: 38391787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus.
    Shen M; Chen D; Zhao R; Zheng X; Gu Y; Yang T; Shi Y
    Front Endocrinol (Lausanne); 2023; 14():1213225. PubMed ID: 37554766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
    J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013.
    Park TH; Kim MS; Lee DY
    Chonnam Med J; 2016 Jan; 52(1):64-9. PubMed ID: 26866002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. May C-peptide index be a new marker to predict proteinuria in anemic patients with type 2 diabetes mellitus?
    Katipoglu B; Comoglu M; Ates I; Yilmaz N; Berker D
    Endocr Regul; 2020 Jan; 54(1):1-5. PubMed ID: 32597149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased length of stay and hospital charges in adolescents with type 1 diabetes and psychiatric illness.
    Munoz FA; Chin C; Kops SA; Kowalek K; Seckeler MD
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):183-186. PubMed ID: 33544538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with diabetic ketoacidosis: a review and a propensity-matched nationwide analysis.
    Shaka H; Wani F; El-Amir Z; Dahiya DS; Singh J; Edigin E; Eseaton P; Kichloo A
    J Investig Med; 2021 Aug; 69(6):1196-1200. PubMed ID: 33972382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BrazIliaN Type 1 & 2 DiabetEs Disease Registry (BINDER): longitudinal, real-world study of diabetes mellitus control in Brazil.
    de Almeida-Pititto B; Eliaschewitz FG; de Paula MA; Ferreira GC
    Front Clin Diabetes Healthc; 2022; 3():934629. PubMed ID: 36992732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal.
    Ndebele NFM; Naidoo M
    Afr J Prim Health Care Fam Med; 2018 Mar; 10(1):e1-e6. PubMed ID: 29781681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admissions for diabetic ketoacidosis in ethnic minority groups in a city hospital.
    Nyenwe E; Loganathan R; Blum S; Ezuteh D; Erani D; Palace M; Ogugua C
    Metabolism; 2007 Feb; 56(2):172-8. PubMed ID: 17224329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.
    Tittel SR; Sondern KM; Weyer M; Poeplau T; Sauer BM; Schebek M; Ludwig KH; Hammer F; Fröhlich-Reiterer E; Holl RW;
    Acta Diabetol; 2020 Oct; 57(10):1245-1253. PubMed ID: 32488499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience.
    Byun DJ; Braunstein R; Flynn J; Zheng J; Lefkowitz RA; Kanbour S; Girotra M
    Diabetes Care; 2020 Dec; 43(12):3106-3109. PubMed ID: 33051330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Patients with Type 1 Diabetes and Additional Autoimmune Disease in the DPV Registry.
    Prinz N; Tittel SR; Bachran R; Birnbacher R; Brückel J; Dunstheimer D; Haberland H; Hess M; Karges W; Oeverink R; Veigel A; Holl RW
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3381-e3389. PubMed ID: 34061946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
    Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R
    Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.